Delirium detection in clinical practice and research: critique of current tools and suggestions for future development

Journal of Psychosomatic Research
Jacob Kean, Karen Ryan

Abstract

Delirium is underrecognized clinically. Many tools have been developed to assist with the diagnosis of delirium, and they vary greatly in purpose, quality, and administration time. It is suggested that future development of delirium assessment instruments be guided by a dichotomization of raters into expert and nonexpert groups. Careful consideration of the needs of the two groups suggests that assessment instruments designed for nonexperts should be entirely objective, whereas those instruments developed for experts should include the full range of constructs associated with the syndrome. This conceptualization is explored in detail, and existing assessment instruments are considered briefly in light of this position.

References

Jan 1, 1992·Journal of Geriatric Psychiatry and Neurology·M S AlbertJ W Rowe
Jan 1, 1991·International Psychogeriatrics·S LevkoffD Evans
Apr 1, 1991·The American Journal of Psychiatry·B LiptzinT T Wetle
Dec 15, 1990·Annals of Internal Medicine·S K InouyeR I Horwitz
Aug 1, 1990·Applied Nursing Research : ANR·P E Vermeersch
Jan 1, 1988·Journal of Gerontological Nursing·M A WilliamsE B Campbell
Jan 1, 1995·Journal of Pain and Symptom Management·M J SmithM M Platt
Nov 1, 1994·General Hospital Psychiatry·P T Trzepacz
Mar 1, 1994·Journal of the American Geriatrics Society·K RockwoodB O'Brien
Nov 1, 1996·Psychosomatics·R P HartL E Rutherford
Mar 1, 1997·Journal of Pain and Symptom Management·W BreitbartS Passik
Jan 30, 1999·International Psychogeriatrics·J McCuskerF Primeau
Sep 4, 1999·Dementia and Geriatric Cognitive Disorders·B Robertsson
Jan 13, 2000·International Psychogeriatrics·D B RolfsonK Rockwood
Jul 13, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·P T TrzepaczN Jimerson
Jan 1, 2003·Clinical Chemistry·Patrick M BossuytUNKNOWN Standards for Reporting of Diagnostic Accuracy
Jun 27, 2003·Dementia and Geriatric Cognitive Disorders·Jouko V LaurilaReijo S Tilvis
Sep 19, 2006·Journal of the American Medical Directors Association·Samuel E SimonEdward R Marcantonio

❮ Previous
Next ❯

Citations

Jan 10, 2013·BMJ Open·Daniel James RyanSuzanne Timmons
Jun 8, 2011·Der Anaesthesist·A IhrigW Herzog
Aug 3, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Daniel H J DavisCarol Brayne
Jul 19, 2011·General Hospital Psychiatry·Gaurav JainParmanand Kulhara
May 10, 2011·The Medical Clinics of North America·Joseph H Flaherty
Jun 23, 2009·Journal of Psychosomatic Research·Eamonn M P EelesRuth E Hubbard
Nov 10, 2015·International Journal of Orthopaedic and Trauma Nursing·Kristine S ToddEleanor McConnell
Apr 29, 2014·Journal of Pain and Symptom Management·Maeve M LeonardPeter G Lawlor
Apr 25, 2014·International Journal of Geriatric Psychiatry·Zoë TiegesAlasdair M J MacLullich
Mar 7, 2015·International Psychogeriatrics·Zoë TiegesAlasdair MacLullich
Jan 27, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Maxine de la CruzEduardo Bruera
Feb 11, 2015·Current Psychiatry Reports·Luigi GrassiMichelle Riba
Jun 13, 2014·Journal of Palliative Medicine·Suzanne RainsfordTracey Bullen
Aug 10, 2019·Health Technology Assessment : HTA·Alasdair Mj MacLullichAlasdair Gray
Oct 8, 2009·The Oncologist·Shirley H Bush, Eduardo Bruera
Jan 23, 2021·Journal of General Internal Medicine·Gregor JohnJacques Donzé
May 18, 2021·Trauma Surgery & Acute Care Open·Danielle Ní ChróinínScott D'Amours

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.